Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Current ratio

Current ratio at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2×-1.3×
Alkermes logo
AlkermesALKS
2.3×-1.1×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
1.4×-0.6×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
9×+0.6×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
2.5×+1.1×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.6×+0.7×

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

total current assets/total current liabilities=3.6×

Based on the most recent quarter.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s current ratio?
Harmony Biosciences Holdings, Inc. (HRMY) reported current ratio of 3.6× in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s current ratio changed year-over-year?
Harmony Biosciences Holdings, Inc.'s current ratio decreased by 2.4% year-over-year, from 3.7× to 3.6×.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s current ratio?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s current ratio has grown at a 13.0% compound annual growth rate (CAGR), from 2× to 3.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.